These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25011212)

  • 1. [Tocolysis in preterm labour--current recommendations].
    Wielgoś M; Bomba-Opoń DA
    Ginekol Pol; 2014 May; 85(5):332-4. PubMed ID: 25011212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness and safety of atosiban vs. pulsatile administration of fenoterol in the treatment of preterm labour].
    Nonnenmacher A; Hopp H; Dudenhausen J
    Z Geburtshilfe Neonatol; 2009 Oct; 213(5):201-6. PubMed ID: 19856243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation.
    Wex J; Connolly M; Rath W
    BMC Pregnancy Childbirth; 2009 Jun; 9():23. PubMed ID: 19538754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preterm labor: current tocolytic options for the treatment of preterm labor.
    Jørgensen JS; Weile LK; Lamont RF
    Expert Opin Pharmacother; 2014 Apr; 15(5):585-8. PubMed ID: 24456411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
    European Atosiban Study Group
    Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.
    French/Australian Atosiban Investigators Group
    Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):177-85. PubMed ID: 11574128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
    Worldwide Atosiban versus Beta-agonists Study Group
    BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial).
    van Vliet EO; Schuit E; Heida KY; Opmeer BC; Kok M; Gyselaers W; Porath MM; Woiski M; Bax CJ; Bloemenkamp KW; Scheepers HC; Jaquemyn Y; van Beek E; Duvekot HJ; Franssen MT; Bijvank BN; Kok JH; Franx A; Mol BW; Oudijk MA
    BMC Pregnancy Childbirth; 2014 Mar; 14():93. PubMed ID: 24589124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.
    Romero R; Sibai BM; Sanchez-Ramos L; Valenzuela GJ; Veille JC; Tabor B; Perry KG; Varner M; Goodwin TM; Lane R; Smith J; Shangold G; Creasy GW
    Am J Obstet Gynecol; 2000 May; 182(5):1173-83. PubMed ID: 10819855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barusiban suppresses oxytocin-induced preterm labour in non-human primates.
    Reinheimer TM
    BMC Pregnancy Childbirth; 2007 Jun; 7 Suppl 1(Suppl 1):S15. PubMed ID: 17570159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dear Colleagues! Tocolysis in preterm labor].
    Spaczyński M
    Ginekol Pol; 2014 May; 85(5):322. PubMed ID: 25011211
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tocolysis for preterm labor without premature preterm rupture of membranes].
    Doret M; Kayem G
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1374-1398. PubMed ID: 28029463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocolysis and preterm labour.
    King JF
    Curr Opin Obstet Gynecol; 2004 Dec; 16(6):459-63. PubMed ID: 15534440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Good sense and nonsense in tocolysis].
    Husslein P; Reisenberger K; Leitich C
    Zentralbl Gynakol; 1995; 117(6):300-3. PubMed ID: 7645357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experience of using oxytocin antagonist atosiban in the rescue therapy of preterm labour].
    Tan JP; Chen H; Du BJ; Liu YL; Wang YH; Zhang JP
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):81-4. PubMed ID: 18683742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute tocolysis for uterine activity reduction in term labor: a review.
    de Heus R; Mulder EJ; Derks JB; Visser GH
    Obstet Gynecol Surv; 2008 Jun; 63(6):383-8; quiz 405. PubMed ID: 18492294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging issues over the choice of nifedipine, beta-agonists and atosiban for tocolysis in spontaneous preterm labour--a proposed systematic review by the International Preterm Labour Council.
    Beattie RB; Helmer H; Khan KS; Lamont RF; McNamara H; Svare J; Tsatsaris V; van Geijn HP;
    J Obstet Gynaecol; 2004 Apr; 24(3):213-5. PubMed ID: 15203610
    [No Abstract]   [Full Text] [Related]  

  • 18. Study protocol for a randomised trial for atosiban versus placebo in threatened preterm birth: the APOSTEL 8 study.
    Klumper J; Breebaart W; Roos C; Naaktgeboren CA; van der Post J; Bosmans J; van Kaam A; Schuit E; Mol BW; Baalman J; McAuliffe F; Thornton J; Kok M; Oudijk MA
    BMJ Open; 2019 Nov; 9(11):e029101. PubMed ID: 31772083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of preterm labor with the oxytocin antagonist atosiban.
    Goodwin TM; Valenzuela G; Silver H; Hayashi R; Creasy GW; Lane R
    Am J Perinatol; 1996 Apr; 13(3):143-6. PubMed ID: 8688103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atosiban for preterm labour.
    Tsatsaris V; Carbonne B; Cabrol D
    Drugs; 2004; 64(4):375-82. PubMed ID: 14969573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.